Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
In vitro and in vivo evaluation of novel chromeno[2,3-d]pyrimidinones as therapeutic agents for triple negative breast cancer.
Carvalho L, de Lima FP, Cerqueira M, Silva A, Pontes O, Oliveira-Pinto S, Guerreiro S, Costa MD, Granja S, Maciel P, Longatto-Filho A, Baltazar F, Proença F, Costa M. Carvalho L, et al. Among authors: baltazar f. RSC Med Chem. 2024 Mar 19;15(4):1362-1380. doi: 10.1039/d3md00682d. eCollection 2024 Apr 24. RSC Med Chem. 2024. PMID: 38665823
Renal cell carcinoma therapy: Current and new drug candidates.
Pontes O, Oliveira-Pinto S, Baltazar F, Costa M. Pontes O, et al. Among authors: baltazar f. Drug Discov Today. 2022 Jan;27(1):304-314. doi: 10.1016/j.drudis.2021.07.009. Epub 2021 Jul 12. Drug Discov Today. 2022. PMID: 34265458 Review.
Targeted treatment of triple-negative-breast cancer through pH-triggered tumour associated macrophages using smart theranostic nanoformulations.
Scialla S, Hanafy MS, Wang JL, Genicio N, Costa Da Silva M, Costa M, Oliveira-Pinto S, Baltazar F, Gallo J, Cui Z, Bañobre-López M. Scialla S, et al. Among authors: baltazar f. Int J Pharm. 2023 Feb 5;632:122575. doi: 10.1016/j.ijpharm.2022.122575. Epub 2023 Jan 2. Int J Pharm. 2023. PMID: 36603672 Free article.
157 results